Home・Список акций・Abbott Laboratories

Abbott Laboratories

Закрыт

СекторЗдравоохранение

109.68 0.91

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

108

Макс.

110.11

Ключевые показатели
By Trading Economics
Доход	-149M 928M
Продажи	1.4B 13B
P/E Средняя по отрасли	34.667 68.51
Прибыль на акцию	1.31
Дивидендная доходность	2.35
Рентабельность продаж	7.369
Сотрудники	122,000
EBITDA	-465M 1.8B

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+11.24% upside

Дивиденды
By Acuity
Дивидендная доходность Средняя по отрасли	2.35% 2.29%
Следующий отчет о доходах	14 окт. 2026 г.
Дата следующей выплаты дивидендов	17 авг. 2026 г.
Следующая эксдивидендная дата	14 окт. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	23B 187B
Предыдущая цена открытия	108.77
Предыдущая цена закрытия	109.68

Abbott Laboratories График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 авг. 2026 г., 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

10 авг. 2026 г., 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

7 авг. 2026 г., 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

6 авг. 2026 г., 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, amid broader market weakness and rising initial jobless claims contributing to tightening expectations.

5 авг. 2026 г., 23:02 UTC

Abbott Laboratories shares are lower in after-market trading, following a brief peak post-close. Broader market conditions may be influencing sentiment amid weaker U.S. job growth data.

4 авг. 2026 г., 20:06 UTC

Abbott Laboratories shares are lower today, tracking broader market declines amid falling crude oil prices and ongoing discussions about potential peace talks.

3 авг. 2026 г., 23:06 UTC

Abbott Laboratories shares are near unchanged in after-market trading, positioned 7.52% above the 20-day moving average and near the upper end of the one-month range.

31 июл. 2026 г., 23:01 UTC

Abbott Laboratories shares are modestly higher in after-market trading. The stock remains elevated, 7.16% above its 20-day moving average.

30 июл. 2026 г., 23:51 UTC

Abbott Laboratories shares are higher in after-market trading, recovering from earlier losses. The stock trades significantly above its 20-day moving average.

29 июл. 2026 г., 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, continuing recent volatility amid mixed global market performance and rising geopolitical tensions in the Middle East.

28 июл. 2026 г., 23:02 UTC

Abbott Laboratories shares are higher in after-market hours, showing notable volatility post-close while remaining above the 20-day moving average. No specific news was identified.

27 июл. 2026 г., 23:02 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market sentiment may be influencing the decline.

24 июл. 2026 г., 20:02 UTC

News

A court dismissed a shareholder lawsuit regarding Abbott Laboratories' 2022 infant formula recall, boosting market sentiment as shares trade higher with increased volume.

23 июл. 2026 г., 23:41 UTC

Abbott Laboratories shares are lower in after-market hours amid broader market weakness, particularly in the bond market, with no specific company news identified.

22 июл. 2026 г., 22:06 UTC

Abbott Laboratories shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month trading range.

21 июл. 2026 г., 19:01 UTC

Abbott Laboratories is lower today, continuing a decline that began Monday. The stock has dropped from an early peak amid no specific news.

20 июл. 2026 г., 23:06 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified. Broader market volatility stems from rising Treasury yields and geopolitical tensions.

Сравнение c конкурентами

Изменение цены

Abbott Laboratories Прогноз

Целевая цена

By TipRanks

11.24% рост

Прогноз на 12 месяцев

Средняя 120.83 USD 11.24%

Максимум 135 USD

Минимум 112 USD

Основано на мнении 15 аналитиков Wall Street, спрогнозировавших целевые цены для Abbott Laboratories на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

15 ratings

Покупка

Удержание

Продажа

Основано на мнении 15 аналитиков, присваивавших рейтинги акциям Abbott Laboratories – Данные за последние 3 месяца.

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.